Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666659 | SCV000790988 | uncertain significance | Glycogen storage disease, type V | 2017-04-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000666659 | SCV000820015 | pathogenic | Glycogen storage disease, type V | 2024-01-18 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 116 of the PYGM protein (p.Leu116Pro). This variant is present in population databases (rs776680924, gnomAD 0.1%). This missense change has been observed in individual(s) with glycogen storage disease and/or McArdle disease (PMID: 10417800, 29143597, 30011114, 34215481; Invitae). This variant is also known as L115P. ClinVar contains an entry for this variant (Variation ID: 551567). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000666659 | SCV002779211 | uncertain significance | Glycogen storage disease, type V | 2022-03-16 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000666659 | SCV003810411 | uncertain significance | Glycogen storage disease, type V | 2019-03-12 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000666659 | SCV004207224 | pathogenic | Glycogen storage disease, type V | 2024-03-07 | criteria provided, single submitter | clinical testing |